Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC

por Wang, Yunchao, Zhang, Nan, Xue, Jingnan, Zhu, Chengpei, Wang, Yanyu, Zhang, Longhao, Yang, Xu, Wang, Hao, Wang, Shanshan, Chao, Jiashuo, Yang, Xiaobo, Zhao, Haitao
Publicado 2023

Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer

por Zhu, Chengpei, Xue, Jingnan, Wang, Yunchao, Wang, Shanshan, Zhang, Nan, Wang, Yanyu, Zhang, Longhao, Yang, Xu, Long, Junyu, Yang, Xiaobo, Sang, Xinting, Zhao, Haitao
Publicado 2023

Accuracy and Precision Evaluation of International Standard Spherical Model by Digital Dental Scanners

por Cai, Hong Xin, Jia, Qi, Shi, HaoYu, Jiang, Yujie, Xue, Jingnan, Chen, ChunXu, Gong, Haotian, Liu, Jie, Lee, Eui-Seok, Jiang, Heng Bo
Publicado 2020

Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a m...

por Zhu, Chengpei, Li, Hu, Yang, Xiaobo, Wang, Shanshan, Wang, Yunchao, Zhang, Nan, Wang, Yanyu, Xue, Jingnan, Zhang, Longhao, Ning, Cong, Yang, Xu, Xun, Ziyu, Chao, Jiashuo, Long, Junyu, Sang, Xinting, Zhu, Zhenyu, Zhao, Haitao
Publicado 2023

Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers

por Mao, Jinzhu, Wang, Dongxu, Long, Junyu, Yang, Xu, Lin, Jianzhen, Song, Yiwei, Xie, Fucun, Xun, Ziyu, Wang, Yanyu, Wang, Yunchao, Li, Yiran, Sun, Huishan, Xue, Jingnan, Song, Yang, Zuo, Bangyou, Zhang, Junwei, Bian, Jin, Zhang, Ting, Yang, Xiaobo, Zhang, Lei, Sang, Xinting, Zhao, Haitao
Publicado 2021

Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinoma

por Xie, Fucun, Chen, Bowen, Yang, Xu, Wang, Huaiyuan, Zhang, Ge, Wang, Yanyu, Wang, Yunchao, Zhang, Nan, Xue, Jingnan, Long, Junyu, Li, Yiran, Sun, Huishan, Xun, Ziyu, Liu, Kai, Chen, Xiangqi, Song, Yang, Yang, Xiaobo, Lu, Zhenhui, Mao, Yilei, Sang, Xinting, Lu, Yinying, Zhao, Haitao
Publicado 2022

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients

por Yang, Xu, Chen, Bowen, Wang, Yanyu, Wang, Yunchao, Long, Junyu, Zhang, Nan, Xue, Jingnan, Xun, Ziyu, Zhang, Linzhi, Cheng, Jiamin, Lei, Jin, Sun, Huishan, Li, Yiran, Lin, Jianzhen, Xie, Fucun, Wang, Dongxu, Pan, Jie, Hu, Ke, Guan, Mei, Huo, Li, Shi, Jie, Yu, Lingxiang, Zhou, Lin, Zhou, Jinxue, Lu, Zhenhui, Yang, Xiaobo, Mao, Yilei, Sang, Xinting, Lu, Yinying, Zhao, Haitao
Publicado 2023